E3 ligase ligand-linker conjugate inhibitor, (S,R,S)-AHPC-PEG3-NH2, Purity ≥98%

Cat. No.: X24-09-YM714

E3 ligase ligand-linker conjugate inhibitor, (S,R,S)-AHPC-PEG3-NH2, Purity ≥98%

Synonym: 2010159-56-3; VH032-PEG3-NH2; VHL ligand-linker conjugate 1; E3 ligase ligand-linker conjugate 5 free base; (2S,4R)-1-[(2S)-2-[[2-[2-[2-(2-Aminoethoxy)ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide; E3 ligase ligand-linker conjugate inhibitor

  • CAS Number: 2010159-56-3
  • Compound CID: 131704495
Product Size
100 mg; 200 mg; 500 mg; 1 g
Price
Datasheet
MSDS
Properties
Description
(S,R,S)-AHPC-PEG3-NH2 is an effective PROTAC inhibitor, that has the ability to prevent the pathway of E3 ligase ligand-linker conjugation. The molecular weight of the compound is 619.77, and its molecular formula is C30H45N5O7S.
Molecular Weight
619.77
Molecular Formula
C30H45N5O7S
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
(S,R,S)-AHPC-PEG3-NH2 displays the significant potential to act as an effective delivery system for other therapeutic agents, enhancing their effectiveness.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0